Baranowska B
Medical Center of Postgraduate Education, Warsaw, Poland.
Cardiovasc Drugs Ther. 1990 Aug;4(4):1113-7. doi: 10.1007/BF01856507.
To elucidate the mechanism of clonidine's effect on hormone release, serum growth hormone (GH), luteinizing hormone (LH), cortisol, and plasma beta-endorphin concentrations were determined after clonidine, naloxone, or the combined therapy of clonidine plus naloxone in six healthy women investigated in the luteal phase of their menstrual cycles. The clonidine injection increased GH levels. Naloxone (0.05, 0.1, and 0.2 mg/kg) decreased serum GH concentrations. Naloxone also increased serum LH, whereas clonidine decreased LH levels. Only the maximal dose of naloxone significantly increased serum cortisol concentrations. Clonidine had opposite effects on cortisol levels. These results demonstrate that combined therapy with clonidine plus naloxone leads to inhibition of the response of GH, LH, and cortisol to clonidine injection.
为阐明可乐定对激素释放的作用机制,在6名处于月经周期黄体期的健康女性中,分别测定了给予可乐定、纳洛酮或可乐定加纳洛酮联合治疗后血清生长激素(GH)、促黄体生成素(LH)、皮质醇以及血浆β-内啡肽的浓度。注射可乐定可提高GH水平。纳洛酮(0.05、0.1和0.2mg/kg)可降低血清GH浓度。纳洛酮还可提高血清LH水平,而可乐定则降低LH水平。仅最大剂量的纳洛酮可显著提高血清皮质醇浓度。可乐定对皮质醇水平有相反的作用。这些结果表明,可乐定加纳洛酮联合治疗可抑制GH、LH和皮质醇对可乐定注射的反应。